Posted by Michael Wonder on 03 Oct 2023
US FDA grants approval for Technegas
2 October 2023 - Strong pre-existing demand expected to drive sales momentum for an immediate US wide rollout.
Cyclopharm announces the company has received US FDA approval to commence commercial sales of Technegas in the US market.
